MX9802543A - Deteccion, prevencion y tratamiento de dermatitis digital papilomatosa. - Google Patents

Deteccion, prevencion y tratamiento de dermatitis digital papilomatosa.

Info

Publication number
MX9802543A
MX9802543A MX9802543A MX9802543A MX9802543A MX 9802543 A MX9802543 A MX 9802543A MX 9802543 A MX9802543 A MX 9802543A MX 9802543 A MX9802543 A MX 9802543A MX 9802543 A MX9802543 A MX 9802543A
Authority
MX
Mexico
Prior art keywords
prevention
detection
treatment
digital dermatitis
papillomatous digital
Prior art date
Application number
MX9802543A
Other languages
English (en)
Inventor
Dale Wallis
James L Wallis
Original Assignee
Dale Wallis
James L Wallis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dale Wallis, James L Wallis filed Critical Dale Wallis
Publication of MX9802543A publication Critical patent/MX9802543A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)

Abstract

La presente invencion se relaciona con el uso de bacteria o bacterina de Serpens spp. en composiciones tales como vacunas, y con los métodos para la deteccion, prevencion y/o tratamiento de Dermatitis Digital Papilomatosa en rumiantes. La presente invencion también proporciona Serpens spp. de la cepa HBL-112 biologicamente pura y bacterina de Serpens spp. de la capa HBL-112 biologicamente pura.
MX9802543A 1996-08-01 1998-04-01 Deteccion, prevencion y tratamiento de dermatitis digital papilomatosa. MX9802543A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2291596P 1996-08-01 1996-08-01

Publications (1)

Publication Number Publication Date
MX9802543A true MX9802543A (es) 1998-11-30

Family

ID=21812090

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9802543A MX9802543A (es) 1996-08-01 1998-04-01 Deteccion, prevencion y tratamiento de dermatitis digital papilomatosa.

Country Status (19)

Country Link
US (2) US6162429A (es)
EP (1) EP0863981B1 (es)
JP (1) JP2000500027A (es)
KR (1) KR19990063786A (es)
CN (1) CN1198185A (es)
AT (1) ATE443755T1 (es)
AU (1) AU732317B2 (es)
BR (1) BR9706543A (es)
CA (1) CA2233570C (es)
DE (1) DE69739592D1 (es)
DK (1) DK0863981T3 (es)
EA (2) EA004873B1 (es)
ES (1) ES2336285T3 (es)
IL (1) IL123922A (es)
MX (1) MX9802543A (es)
NZ (1) NZ330050A (es)
PT (1) PT863981E (es)
TR (1) TR199800597T1 (es)
WO (1) WO1998005755A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241992B1 (en) * 1997-09-08 2001-06-05 University Technologies International, Inc. Bovine footrot treatment and prevention
US6667040B2 (en) 1997-09-08 2003-12-23 University Technologies International, Inc. Bovine footrot treatment and prevention
US6287575B1 (en) * 1997-10-03 2001-09-11 The Regents Of The University Of California Vaccine against papillomatous digital dermatitis (PDD)
US7097861B1 (en) 2003-02-07 2006-08-29 Jones-Hamilton Co. Method of treating livestock footbath solutions
US8703104B2 (en) * 2007-10-25 2014-04-22 Ecolab Usa Inc Use of metal astringents for the treatment of hairy heel warts
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
US10022458B2 (en) 2015-03-05 2018-07-17 Iowa State University Research Foundation, Inc. Animal model protocol, diagnostic, therapeutic and vaccine against digital dermatitis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175516A (en) * 1966-04-15 1969-12-23 Science Union & Cie New Phenyl-Aminopropane Derivatives and Preparations Containing them
US3673205A (en) * 1970-03-25 1972-06-27 American Cyanamid Co 6-(m-AMINO AND SUBSTITUTED-AMINO PHENYL)-2,3,5,6-TETRAHYDRO{8 2,1-b{9 THIAZOLES AND METHOD OF USE
US4029763A (en) 1974-08-05 1977-06-14 Mount Sinai School Of Medicine Of The City University Of New York Influenza vaccine containing purified neuraminidase antigen and method of using the same
DE2930706A1 (de) * 1979-07-28 1981-02-05 Medac Klinische Spezialpraep Verfahren zum nachweis von erregerspezifischen antikoerpern
JPS6067474A (ja) * 1983-09-24 1985-04-17 Wakamoto Pharmaceut Co Ltd 新規な１，３，４−チアジアゾ−ル誘導体及びそれを有効成分とする抗潰瘍剤
US4746613A (en) * 1984-03-02 1988-05-24 Wichmann Robert W Poultry diseases bacterin preparation
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
US5630379A (en) * 1996-02-12 1997-05-20 Ssi Corporation Electrically controlled spraying device for cleaning and treating animals
US6287575B1 (en) * 1997-10-03 2001-09-11 The Regents Of The University Of California Vaccine against papillomatous digital dermatitis (PDD)

Also Published As

Publication number Publication date
CN1198185A (zh) 1998-11-04
NZ330050A (en) 2000-01-28
ATE443755T1 (de) 2009-10-15
US6884412B1 (en) 2005-04-26
CA2233570A1 (en) 1998-02-12
EA200001056A1 (ru) 2001-04-23
WO1998005755A1 (en) 1998-02-12
DE69739592D1 (de) 2009-11-05
KR19990063786A (ko) 1999-07-26
PT863981E (pt) 2010-01-04
TR199800597T1 (xx) 1998-06-22
CA2233570C (en) 2013-02-19
EP0863981A1 (en) 1998-09-16
EA199800243A1 (ru) 1998-10-29
AU3809997A (en) 1998-02-25
ES2336285T3 (es) 2010-04-09
US6162429A (en) 2000-12-19
EP0863981B1 (en) 2009-09-23
EA004873B1 (ru) 2004-08-26
AU732317B2 (en) 2001-04-12
IL123922A (en) 2005-07-25
BR9706543A (pt) 1999-12-28
EP0863981A4 (en) 2002-09-18
DK0863981T3 (da) 2010-02-01
JP2000500027A (ja) 2000-01-11
EA002181B1 (ru) 2002-02-28

Similar Documents

Publication Publication Date Title
GR970300016T1 (en) Lactobacillus strains of human origin, their compositions and uses thereof
EP1032417A4 (en) BACTERIAL VACCINES, CONTAINING AUXOTROPHIC DELAYED LISTERIA STRAINS, WHICH HETEROLOGIST EXPRESS ANTIGENS
MXPA02010826A (es) Compuestos y metodos para el tratamiento y la prevencion de infeccion bacteriana.
PL348973A1 (en) Oral administration of lactobacillus for the treatment and prevention of urogenital infection
PL349028A1 (en) Cancer treatment composition and method using natural plant essential oils
NZ508110A (en) Attenuated mutants of salmonella which constitutively express the Vi antigen
BG100960A (en) Dosage forms for controlled release of azitromycin
BG102818A (en) D-manitol and method for its preparation
IL145795A0 (en) Mutant human cd80 and compositions for and methods of making and using the same
MX9802543A (es) Deteccion, prevencion y tratamiento de dermatitis digital papilomatosa.
AU1074902A (en) Kahalalide f
GR3036503T3 (en) Pharmaceutical formulations of cefaclor
CA2064029A1 (en) Use of mycobacterium vaccae in the prevention of aids
EP1303300A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
MD916G2 (ro) Unguent pentru tratamentul afecţiunilor dentare
WO2005004791A3 (en) Compounds and methods for the treatment and prevention of bacterial infection
WO2004067718A3 (en) Necrosis-deficient mutants of tuberculosis bacteria
MD970208A (en) Nutritious medium for Enterobacteriaceae family representatives selective detection
AU2003238341A1 (en) Use of urea-adjuvated polypeptides for diagnosis, prophylaxis and treatment
MXPA01010449A (es) Composicion y metodo util para el tratamiento del colico.
MD20010055A (ro) Preparat microbian sanogenic pentru profilaxia şi tratamentul disbacteriozei intestinale
UA9768A (uk) Мастильна композиція
UA34273A (uk) Спосіб профілактики вірусно-бактеріальних інфекцій респіраторного тракту у дітей з лімфатичним діатезом

Legal Events

Date Code Title Description
FG Grant or registration